Published in J Virol on March 01, 2001
A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics (2006) 2.25
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol (2002) 1.42
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Infection of tick cells and bovine erythrocytes with one genotype of the intracellular ehrlichia Anaplasma marginale excludes infection with other genotypes. Clin Diagn Lab Immunol (2002) 1.19
Vaccine-induced pathogen strain replacement: what are the mechanisms? J R Soc Interface (2008) 1.18
Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis (2006) 1.17
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J Virol (2007) 0.94
The evolution of bovine viral diarrhea: a review. Can Vet J (2002) 0.88
Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART). Hepatology (2007) 0.83
Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection. Clin Exp Immunol (2003) 0.83
A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level. J Virol (2014) 0.81
Human liver transplantation as a model to study hepatitis C virus pathogenesis. Liver Transpl (2009) 0.79
Eilat virus induces both homologous and heterologous interference. Virology (2015) 0.78
Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin. PLoS One (2015) 0.77
Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons. J Clin Microbiol (2016) 0.75
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res (1990) 9.28
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Defective viral particles and viral disease processes. Nature (1970) 7.24
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med (1995) 3.41
Immunity in hepatitis C infection. J Infect Dis (1992) 2.28
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat (1996) 1.94
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
The red queen reigns in the kingdom of RNA viruses. Proc Natl Acad Sci U S A (1994) 1.83
Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology (1998) 1.49
Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis (1999) 1.27
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology (1996) 1.27
Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Virol (1996) 1.26
Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology (1994) 1.24
Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol (1996) 1.14
Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol (1996) 1.14
PCR-based site-directed mutagenesis using primers with mismatched 3'-ends. Nucleic Acids Res (1990) 1.08
Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology (1993) 1.06
Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology (1996) 1.06
Cold-adapted vaccine strains of influenza A virus act as dominant negative mutants in mixed infections with wild-type influenza A virus. Virology (1990) 1.03
Dominant-negative mutants as antiviral agents: simultaneous infection with the cold-adapted live-virus vaccine for influenza A protects ferrets from disease produced by wild-type influenza A. J Infect Dis (1991) 0.93
Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol (1996) 0.92
Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. J Clin Microbiol (1994) 0.91
Hepatitis C virus genotypes in Belgian hemophiliacs. J Med Virol (1995) 0.85
Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. J Infect Dis (1997) 0.83
Hepatitis C virus genotypes in northern Italy: clinical and virological features. J Clin Microbiol (1996) 0.77
A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol (1989) 6.59
Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell (1990) 4.60
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38
A strong sequence homology exists between the major RNA polymerase sigma factors of Bacillus subtilis and Escherichia coli. J Biol Chem (1985) 3.28
Multiple procaryotic ribonucleic acid polymerase sigma factors. Microbiol Rev (1986) 3.25
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis (2001) 2.91
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet (2000) 2.85
A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol (1997) 2.65
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57
The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev (2008) 2.39
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19
The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology (1989) 2.19
Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. BJOG (2007) 2.16
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol (2008) 2.13
Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification. J Clin Microbiol (1992) 2.03
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98
Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion (1992) 1.95
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88
Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant (2011) 1.88
Nucleotide sequence and organization of Bacillus subtilis RNA polymerase major sigma (sigma 43) operon. Nucleic Acids Res (1986) 1.86
Fall in deaths from respiratory disease. Lancet (1991) 1.78
Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol (1997) 1.77
Tracking patients who wander: ethics and technology. Lancet (1994) 1.74
Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2014) 1.71
Blood transfusion. Nurs Stand (2002) 1.70
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68
rpoD operon promoter used by sigma H-RNA polymerase in Bacillus subtilis. J Bacteriol (1988) 1.68
Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis (2000) 1.66
Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol (1999) 1.65
Tioman virus, a novel paramyxovirus isolated from fruit bats in Malaysia. Virology (2001) 1.62
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry (2004) 1.60
Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59
Female control of sexuality: illusion or reality? Use of vaginal products in south west Uganda. Soc Sci Med (2001) 1.58
Promoter switching during development and the termination site of the sigma 43 operon of Bacillus subtilis. Mol Gen Genet (1987) 1.57
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56
Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv (1999) 1.55
Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg (1999) 1.55
Common evolutionary origin of the phage T4 dam and host Escherichia coli dam DNA-adenine methyltransferase genes. J Bacteriol (1985) 1.52
Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology (1998) 1.49
Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49
Pain following colonoscopy: elimination with carbon dioxide. Gastrointest Endosc (1992) 1.48
The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology (1996) 1.48
Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem (1998) 1.47
Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology (2001) 1.47
Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis. Mayo Clin Proc (1991) 1.44
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity. Am J Transplant (2009) 1.44
Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc (1994) 1.43
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg (1998) 1.42
Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain. J Gen Virol (2000) 1.41
Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.39
Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol (1994) 1.39
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery (1998) 1.38
Inosine prabonex in the treatment of chronic hepatitis C. J Hepatol (1992) 1.38
Bacillus subtilis subtilisin gene (aprE) is expressed from a sigma A (sigma 43) promoter in vitro and in vivo. J Bacteriol (1989) 1.37
Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol (2000) 1.36
Enhanced levels of the aroma and flavor compound S-linalool by metabolic engineering of the terpenoid pathway in tomato fruits. Plant Physiol (2001) 1.36
Catabolite-resistant sporulation (crsA) mutations in the Bacillus subtilis RNA polymerase sigma 43 gene (rpoD) can suppress and be suppressed by mutations in spo0 genes. Proc Natl Acad Sci U S A (1985) 1.36
A pathway to the GP: the pharmaceutical 'consultation' as a first port of call in primary health care. Fam Pract (1997) 1.35
A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts. J Immunol (1989) 1.32
Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol (2000) 1.31
Sildenafil in primary pulmonary hypertension. N Engl J Med (2000) 1.31
Co-circulation of diverse paramyxoviruses in an urban African fruit bat population. J Gen Virol (2011) 1.30
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology (2001) 1.29
Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology (1979) 1.28
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation (1998) 1.28
Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology (1998) 1.27
Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane. Proc Natl Acad Sci U S A (1987) 1.27
Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol (1997) 1.26
Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.26
The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol (1997) 1.25
Bacillus subtilis dnaE encodes a protein homologous to DNA primase of Escherichia coli. J Biol Chem (1985) 1.24
An acceptability study of female-controlled methods of protection against HIV and STDs in south-western Uganda. Int J STD AIDS (2000) 1.24
Human Hendra virus infection causes acute and relapsing encephalitis. Neuropathol Appl Neurobiol (2008) 1.22